Results 51 to 60 of about 199,505 (255)
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Collaterals are crucial factors that influence the infarct growth rate (IGR). We aimed to determine whether a comprehensive multimodal collateral score (MCS), incorporating collateral assessment at the arterial, tissue, and venous levels, is associated with functional independence and provides incremental prognostic value over ...
Giorgio Busto +12 more
wiley +1 more source
Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN‐Digenic Myopathy
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective SRPK3/TTN‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN‐digenic myopathy in one previously reported and seven newly identified pediatric patients.
Rotem Orbach +23 more
wiley +1 more source
Legal Risk Management in Sharia Bank Contracts
Ijtimā'iyyaA crucial aspect of Islamic banking activities is the existence of contracts, which are agreements that bind the parties in financial transactions.
Rahmat Husein Lubis, Sarmiana Batubara
doaj +1 more source
Coordination risks as a variety of legal risks
Russian Journal of Legal Studies, 2016 In this paper we consider a new approach to the study of the relevant aspects of the coordination law. In this form, this problem was not considered. First individual, the most theoretically relevant and practically valuable, the legal elements of coordination are considered from the standpoint of legal experience, practice and technology.
openaire +2 more sources
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou +16 more
wiley +1 more source
Early Recognition of Treatment‐Responsive Rapidly Progressive Dementia: The Modified STAM3mP Score
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Early identification of patients with treatment‐responsive rapidly progressive dementia (RPD) is important as early treatment improves outcomes. The STAM3P score identifies treatment‐responsive RPD using “high risk” presenting features. We optimized performance by adding a time component (i.e., dementia within 3 months) and validated the ...
R. W. van Steenhoven +16 more
wiley +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit +11 more
wiley +1 more source
LEGAL AND COMPLIANCE RISKS OF NEW TECHNOLOGIES
Ankara Sosyal Bilimler Üniversitesi Hukuk Fakültesi DergisiTechnology is developing parabolically. This development affects businesses' way of conduct. Both internal and external processes of enterprises are digitalized in order to increase efficiency and flexibility. Yet, the digitalization creates a variety of
Yasemin Güllüoğlu, Fatih Erdemir
doaj +1 more source
RISKS: DIAGNOSING AND ELIMINATING
Russian Journal of Economics and Law, 2016 Objective: to develop conceptual theoretical and legal provisions and scientific recommendations on the identification, analysis and elimination of risk. Methods: universal dialectic method of cognition, as well as scientific and private research methods
YU. A. Tikhomirov
doaj +1 more source
Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito +8 more
wiley +1 more source